Home » PFIZER COULD LOSE BILLIONS IN LIPITOR PATENT RULING
PFIZER COULD LOSE BILLIONS IN LIPITOR PATENT RULING
A federal appeals court dealt Pfizer Inc. a legal setback Wednesday when it issued a ruling that threatens to cut 15 months from the patent life of its popular cholesterol drug Lipitor, the world's biggest-selling medicine.
CNN
Money
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May